71
Views
9
CrossRef citations to date
0
Altmetric
Article

Long‐term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates

, , &
Pages 487-493 | Received 23 Sep 2002, Accepted 04 Jun 2003, Published online: 09 Jul 2009

References

  • Borboroglu P, Kane C, Ward J, Roberts J, Sands J. Immediate and postoperative complications of trans-urethral prostatectomy in the 1990s. J Urol 1999; 162: 1307–10.
  • Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC. Writing Committee. Transurethral prostatectomy: im-mediate and postoperative complications. A cooperative study of 134 participating institutions evaluating 3885 patients. J Urol 1989; 141: 243–7.
  • Holtgrewe HE. Surgical management of benign prostatic hyperplasia in 2001-a pause for thought. J Urol 2001; 166: 177.
  • Keoghane SR, Cranston DW, Lawrence KC, Doll HA, Fellows GJ, Smith JC. The Oxford laser trial: a double-blind randomized controlled trial of contact vaporization of the prostate against transurethral resection; prelimin-ary results. Br J Urol 1996; 77: 328–35.
  • Tuhkanen K, Heino A, Ala-Opas M. Contact laser prostatectomy compared to TURP in prostatic hyper-plasia smaller than 40 ml: six-month follow-up with complex urodynamic assessment. Scand J Urol Nephrol 1999; 33: 31–4.
  • Tuhkanen K, Heino A, Ala-Opas M. Hybrid laser treatment compared to TURP in symptomatic bladder outflow obstruction caused by a large benign prostate: a prospective randomised trial with six-month follow-up. BJU Int 1999; 84: 805–9.
  • McAllister WJ, Absalom MJ, Mir K, Shivde S, Anson K, Kirby RS, et al. Does endoscopic laser ablation of the prostate stand the test of time? Five year results from a multicentre randomised controlled trial of endoscopic laser ablation against transurethral resection of the prostate. BJU Int 2000; 85: 437–9.
  • Daelin L, Frugard J. Transurethral microwave thermo-therapy in the management of lower urinary tract symptoms from benign prostatic obstruction. Scand J Urol Nephrol 2000; 34: 304–8.
  • Madersbacher S, Schatzl G, Djavan B, Stulning T, Marberger M. Long-term outcome of transrectal high-intensity focused ultrasound for benign prostatic hyper-plasia. Eur Urol 2000; 37: 687–94.
  • Tubaro A, de la Rosette J, Hofner K, Renzwtti R, Carter S. Long-term follow-up of contact laser prostatectomy. Eur Urol 2000; 37 (Suppl 2): 145 (Abstract 567).
  • Schatzl G, Madersbacher S, Djavan B, Lang T, Marberger M. Two-year results of transurethral resection of the prostate versus four 'less invasive' treatment options. Eur Urol 2000; 37: 695–701.
  • Daughtry JD, Rodan BA. Transurethral laser prostatec-tomy: a comparison of contact tip mode and lateral firing free beam mode. J Clin Laser Med Surg 1993; 11:21–8.
  • Gilling PJ, Mackey M, Cresswell M, Kennett K, Kabalin JN, Fraundorfer MR. Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year follow-up. J Urol 1999; 162: 1640–4.
  • Matsouka K, Ida S, Tomiyasu K, Shimada A, Noda S, et al. Transurethral holmium laser resection of the prostate. J Urol 2000; 163: 515–8.
  • Keoghane SR, Sullivan ME, Doll HA, Kourambas J, Cranston DW. Five-year data from the Oxford Laser Prostatectomy Trial. BJU Int 2000; 86: 227–8.
  • Floratos DL, Sonke GS, Fransisca EAE, Debruyne FMJ, de la Rosette J. Durability of laser prostatectomy. Eur Urol 2000; 37 (Suppl 2): 144 (Abstract 575).
  • Bryan NP, Hastie KJ, Chapple CR. Randomised prospective trial of contact laser prostatectomy (CLAP) versus visual laser coagulation of the prostate for the treatment of benign prostatic hyperplasia. Eur Urol 2000; 38: 265–71.
  • Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF, et al. Mortality and reoperations after open and transurethral resection of the prostate for BPE. N Engl J Med 1989; 320: 1120–4.
  • Hald T, Nordling J, Andersen JT, Bilde T, Meyhoff HEI, Walter S. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyper-plasia. Scand J Urol Nephrol Suppl 1991; 138: 59–62.
  • Abrams P. Objective evaluation of bladder outlet obstruction. Br J Urol 1995; 76: 11–5.
  • Abrams PH, Griffiths DJ. The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol 1979; 51: 129–34.
  • Griffiths D, 116fner H, van Mastrigt R, Rolleman HJ, Spangberg A, Gleason D. Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. Neurourol Urodyn 1997; 16: 1–18.
  • Chen S-S, Hong J-G, Hsiao Y-J, Chang LS. The correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia. BJU Int 2000; 85: 79–82.
  • Floratos DL, de la Rosette JMCH. The value of urodynamics in laser prostatectomy. Eur Urol 2000; 37: 509–16.
  • Jensen KM, Jorgensen TB, Mogensen P. Long-term predictive role of urodynamics: an 8-year follow-up of prostatic surgery for lower urinary tract symptoms. Br J Urol 1996; 78: 213–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.